SCHEMBL4965568

SCHEMBL4965568

O=c1c2ncc3c(c(-c4ccccn4)cn3Cc3ccc(F)cc3)c2ccn1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.39
▸ TP53 P04637 2/20 0.38
▸ NFATC1 O95644 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ DYRK1A Q13627 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ EGLN1 Q9GZT9 1/20 0.37
▸ RAB9A P51151 1/20 0.36
▸ ENPP2 Q13822 1/20 0.36
▸ CYP19A1 P11511 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ GPR39 O43194 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ CHRM1 P11229 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3495444 0.83 TP53 (0.41) POLBTP53MEN1KMT2AALDH1A1
SCHEMBL3497512 0.82 TP53 (0.45) POLBTP53MEN1KMT2AALDH1A1
SCHEMBL14302890 0.81 KDM4E (0.43) POLBTP53MEN1KMT2AALDH1A1
SCHEMBL4964868 0.81 CYP19A1 (0.39) POLBTP53NFATC1GSK3BDYRK1A
SCHEMBL14302885 0.80 ALDH1A1 (0.37) POLBTP53MEN1KMT2AALDH1A1
SCHEMBL5424463 0.80 FYN (0.45) BRD4
SCHEMBL3496814 0.79 HTT (0.39) POLBTP53MEN1KMT2AALDH1A1
SCHEMBL5223852 0.79 ALDH1A1 (0.41) TP53KMT2AALDH1A1KDM4ELMNA
SCHEMBL3497511 0.78 KMT2A (0.41) POLBMEN1KMT2AALDH1A1KDM4E
SCHEMBL3496608 0.78 KDM4E (0.39) POLBTP53ALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1934220-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME Pfizer Products Incorporated (US) 2008-06-25 — — EP disclosed
US-20070099915-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER INC. 2007-05-03 — — US disclosed
US-20070099915-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER INC. 2007-05-03 — — US disclosed
US-20070099915-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER INC. 2007-05-03 — — US disclosed
WO-2007042883-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER PRODUCTS INC. (US) 2007-04-19 — — WO disclosed
WO-2007042883-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME PFIZER PRODUCTS INC. (US) 2007-04-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099915-A1 INHIBITORS OF THE HIV INTEGRASE ENZYME IMPDH1, INTS9, TYMP POLB 34/4885TP53 537/4885NFATC1 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback